Norman S. Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Norman S. Miller has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Norman G. Hoffmann
Center for Alcohol and Addiction Studies, Brown University, Providence, RI
2 shared publicationsAndrea Greenfeld
1 shared publicationBoris M. Astrachan
Department of Psychiatry, University of Illinois at Chicago
1 shared publicationFred Ninonuevo
New Standards, Inc., St. Paul, Mich
1 shared publicationJoseph A. Flaherty
1 shared publication- Kathleen T. Brady
Department of Psychiatry, Medical University of South Carolina, Charleston
1 shared publication
Latest Publications
- Open Access
- 24 July 2017
- Published by Juniper Publishers in Global Journal of Addiction & Rehabilitation Medicine
- Vol. 2 (4)
Opioid use Disorder for Prescription Opioid Medications
- 24 July 2017
- Published by Juniper Publishers in Global Journal of Addiction & Rehabilitation Medicine
- Vol. 2 (4)
Open AccessOpioid use Disorder for Prescription Opioid Medications
- 27 August 2007
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 26 (sup1) , 65-71
Opiate Prescription Medication Dependence and Pain Perceptions
Our study showed that the perception of pain lessens with detoxification from chronic prescription opiate medications. Thus, removal of opiates resulted in less pain, and chronic administration of opiates actually increased pain perceptions. The underlying pathophysiology of increased pain sensitivity from chronic administration is not well understood. However, the enhanced pain from the development of tolerance and dependence is a common phenomenon. Clinicians are advised to limit their prescribing of opiate drugs to patients on a chronic basis. Further, unresolved pain complaints, and continued complaints of pain despite escalating doses of opiate medications suggest addiction and its adverse consequences. Identification of addiction and detoxification is the proper approach to pain management in chronic opiate administration.
- 27 August 2007
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 26 (sup1) , 65-71
Opiate Prescription Medication Dependence and Pain Perceptions
Our study showed that the perception of pain lessens with detoxification from chronic prescription opiate medications. Thus, removal of opiates resulted in less pain, and chronic administration of opiates actually increased pain perceptions. The underlying pathophysiology of increased pain sensitivity from chronic administration is not well understood. However, the enhanced pain from the development of tolerance and dependence is a common phenomenon. Clinicians are advised to limit their prescribing of opiate drugs to patients on a chronic basis. Further, unresolved pain complaints, and continued complaints of pain despite escalating doses of opiate medications suggest addiction and its adverse consequences. Identification of addiction and detoxification is the proper approach to pain management in chronic opiate administration.
- 1 November 2006
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 13 (6) , 527-533
Failure of Enforcement Controlled Substance Laws in Health Policy for Prescribing Opiate Medications: A Painful Assessment of Morbidity and Mortality
Controlled substances can be used for legitimate medical purposes to relieve pain and suffering, and allow management of medical and surgical conditions, whether acute or chronic in duration. However, because these are attractive, addicting drugs, diversion from sources such as physicians and pharmacists can lead to serious health problems. Of importance is that addiction to opiate medications can interfere with treatment of the original pain condition, and can lead to life threatening states because of poor judgment and depressed mood in the users. Consequently, the public has a vested interest in protecting the medical uses of these medications on the one hand, although reducing the morbidity and mortality from their diversion and addictive use. The controlled substance laws contain 3 sources of policy framework that governs the medical use and diversion of controlled substances: (1) international treaties, (2) federal laws and regulations, and (3) state laws and regulations. These laws are aimed at balancing the need to controlling use with adverse consequences against the therapeutic benefits opiate medications provide the public.
- 1 November 2006
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 13 (6) , 527-533
Failure of Enforcement Controlled Substance Laws in Health Policy for Prescribing Opiate Medications: A Painful Assessment of Morbidity and Mortality
Controlled substances can be used for legitimate medical purposes to relieve pain and suffering, and allow management of medical and surgical conditions, whether acute or chronic in duration. However, because these are attractive, addicting drugs, diversion from sources such as physicians and pharmacists can lead to serious health problems. Of importance is that addiction to opiate medications can interfere with treatment of the original pain condition, and can lead to life threatening states because of poor judgment and depressed mood in the users. Consequently, the public has a vested interest in protecting the medical uses of these medications on the one hand, although reducing the morbidity and mortality from their diversion and addictive use. The controlled substance laws contain 3 sources of policy framework that governs the medical use and diversion of controlled substances: (1) international treaties, (2) federal laws and regulations, and (3) state laws and regulations. These laws are aimed at balancing the need to controlling use with adverse consequences against the therapeutic benefits opiate medications provide the public.
- 1 September 2006
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 13 (5) , 436-444
Effects of Opioid Prescription Medication Dependence and Detoxification on Pain Perceptions and Self-Reports
The purpose of this work is to document whether prescription opioid medications used for pain enhanced or worsened pain syndromes from medical conditions in patients who received a diagnosis of prescription opioid dependence as determined by a diagnosis by Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria. Further, whether detoxification improved or worsened pain perceptions and self-reports in patients who chronically administered prescription opioid medications. Our study consisted of a retrospective sample of patients taken from the Addiction Treatment Unit at St Lawrence Hospital in Lansing, MI. Patients were selected from those who voluntarily sought detoxification from opioid medications in an inpatient setting. Selection criteria for the study consisted of a DSM-IV diagnosis of opioid prescription medication dependence, willingness to undergo medical detoxification, cooperation with self-report scales, and abstinence from opioid medications. Study patients were randomly selected from discharges in patient census for the years 2001 to 2003. The significant findings were that self-reported pain scores improved during the detoxification from admission to discharge, from a mean of 5.5 at admission to mean of 3.4 at discharge (0 is no pain and 10 is the most pain). The detoxification period extended to an average of 5 days. Whereas oxycodone CR (OxyContin) produced higher levels of self-reported pain at admission than at discharge, and these patients experienced significant levels of pain reduction with decremental opioid doses as with other opioid medications. Patients with a DSM-IV diagnosis of prescription opioid dependence reported (self) less pain with detoxification and abstinence from the opioid medications.
- 1 September 2006
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 13 (5) , 436-444
Effects of Opioid Prescription Medication Dependence and Detoxification on Pain Perceptions and Self-Reports
The purpose of this work is to document whether prescription opioid medications used for pain enhanced or worsened pain syndromes from medical conditions in patients who received a diagnosis of prescription opioid dependence as determined by a diagnosis by Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria. Further, whether detoxification improved or worsened pain perceptions and self-reports in patients who chronically administered prescription opioid medications. Our study consisted of a retrospective sample of patients taken from the Addiction Treatment Unit at St Lawrence Hospital in Lansing, MI. Patients were selected from those who voluntarily sought detoxification from opioid medications in an inpatient setting. Selection criteria for the study consisted of a DSM-IV diagnosis of opioid prescription medication dependence, willingness to undergo medical detoxification, cooperation with self-report scales, and abstinence from opioid medications. Study patients were randomly selected from discharges in patient census for the years 2001 to 2003. The significant findings were that self-reported pain scores improved during the detoxification from admission to discharge, from a mean of 5.5 at admission to mean of 3.4 at discharge (0 is no pain and 10 is the most pain). The detoxification period extended to an average of 5 days. Whereas oxycodone CR (OxyContin) produced higher levels of self-reported pain at admission than at discharge, and these patients experienced significant levels of pain reduction with decremental opioid doses as with other opioid medications. Patients with a DSM-IV diagnosis of prescription opioid dependence reported (self) less pain with detoxification and abstinence from the opioid medications.
- 1 June 2006
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 36 (6)
Physicians and the Controlled Substance Laws for Opiate Prescription Medications
Physicians are in a unique position to assess and treat people who seek evaluation and treatment for medically related health problems associated with drug and alcohol use and addiction. Well-known medical complications result from drug disorders, including addiction to opiates. Addictions are too numerous to cite but prominently include widespread medical diseases. ABOUT THE AUTHOR Dr. Miller is clinical professor, Department of Medicine, Michigan State University, East Lansing, MI. Address reprint requests to: Norman S. Miller, MD, JD, 321 Woodland Pass, Suite 300, East Lansing, MI 48823; or e-mail norman.miller@hc.msu.edu.
- 1 June 2006
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 36 (6)
Physicians and the Controlled Substance Laws for Opiate Prescription Medications
Physicians are in a unique position to assess and treat people who seek evaluation and treatment for medically related health problems associated with drug and alcohol use and addiction. Well-known medical complications result from drug disorders, including addiction to opiates. Addictions are too numerous to cite but prominently include widespread medical diseases. ABOUT THE AUTHOR Dr. Miller is clinical professor, Department of Medicine, Michigan State University, East Lansing, MI. Address reprint requests to: Norman S. Miller, MD, JD, 321 Woodland Pass, Suite 300, East Lansing, MI 48823; or e-mail norman.miller@hc.msu.edu.
- 1 June 2006
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 36 (6)
Prescription Opiate Medications: Clinical Assessment and Treatment of Addiction, Tolerance, and Dependence
The 2003 National Survey on Drug Abuse and Health (NSDUH) demonstrated that 2.6 million people in the United States misused pain relievers, including hydrocodone and oxycodone. The misuse of prescription medicines affects a broad range of users, particularly older adults, adolescents, and women. There has been a sharp increase in new users of prescription drugs for nonmedical purposes, particularly painkillers, among teenagers and young adults, including both 12- to 17-year-olds (2.9% increase) and 18- to 25-year-olds (3.7% increase). ABOUT THE AUTHOR Dr. Miller is clinical professor, Department of Medicine, Michigan State University, East Lansing, MI. Address reprint requests to: Norman S. Miller, MD, JD, 321 Woodland Pass, Suite 300, East Lansing, MI 48823; or e-mail norman.miller@hc.msu.edu. Dr. Miller disclosed no relevant financial relationships.
- 1 June 2006
- Published by SLACK, Inc. in Psychiatric Annals
- Vol. 36 (6)
Prescription Opiate Medications: Clinical Assessment and Treatment of Addiction, Tolerance, and Dependence
The 2003 National Survey on Drug Abuse and Health (NSDUH) demonstrated that 2.6 million people in the United States misused pain relievers, including hydrocodone and oxycodone. The misuse of prescription medicines affects a broad range of users, particularly older adults, adolescents, and women. There has been a sharp increase in new users of prescription drugs for nonmedical purposes, particularly painkillers, among teenagers and young adults, including both 12- to 17-year-olds (2.9% increase) and 18- to 25-year-olds (3.7% increase). ABOUT THE AUTHOR Dr. Miller is clinical professor, Department of Medicine, Michigan State University, East Lansing, MI. Address reprint requests to: Norman S. Miller, MD, JD, 321 Woodland Pass, Suite 300, East Lansing, MI 48823; or e-mail norman.miller@hc.msu.edu. Dr. Miller disclosed no relevant financial relationships.
- 31 December 2004
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 27 (4)
Addictive Disorders
- 31 December 2004
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 27 (4)
Addictive Disorders
- 1 December 2004
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 27 (4) , 689-708
Prescription opiate medications: medical uses and consequences, laws and controls
- 1 December 2004
- Published by Elsevier in Psychiatric Clinics of North America
- Vol. 27 (4) , 689-708
Prescription opiate medications: medical uses and consequences, laws and controls
- 1 January 2004
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 11 (1) , 26-32
Patient Characteristics and Risks Factors for Development of Dependence on Hydrocodone and Oxycodone
The purpose of the study was to document the substantial increase in problematic use of hydrocodone and oxycodone in an addiction treatment population. Our study consisted of a retrospective review of medical records from all patients admitted and discharged in 2000 from Sparrow/St. Lawrence Addiction Detoxification Unit (N = 534). A literature review was conducted in medical journals, governmental groups, and reports including Drug Abuse Warning Network, Pharmacy Times, and National Household Survey on Drug Abuse. More than 144 patients (27%) were dependent on prescription opiate medications. The most frequently mentioned medication was Vicodin (hydrocodone) (53% of the users) followed by OxyContin (oxycodone) (19%). Physicians commonly prescribed these medications (75% of the cases). Predictors of dependence on opiate medications included substance-related diagnoses, positive toxicology for opiates, and other medical diagnoses. Patients under the care of physicians who have other drug dependence diagnoses and medical complaints appear at risk of developing dependence on prescription opiate medications. Proper evaluation and intervention can limit adverse consequences of prescription opiate medications.
- 1 January 2004
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 11 (1) , 26-32
Patient Characteristics and Risks Factors for Development of Dependence on Hydrocodone and Oxycodone
The purpose of the study was to document the substantial increase in problematic use of hydrocodone and oxycodone in an addiction treatment population. Our study consisted of a retrospective review of medical records from all patients admitted and discharged in 2000 from Sparrow/St. Lawrence Addiction Detoxification Unit (N = 534). A literature review was conducted in medical journals, governmental groups, and reports including Drug Abuse Warning Network, Pharmacy Times, and National Household Survey on Drug Abuse. More than 144 patients (27%) were dependent on prescription opiate medications. The most frequently mentioned medication was Vicodin (hydrocodone) (53% of the users) followed by OxyContin (oxycodone) (19%). Physicians commonly prescribed these medications (75% of the cases). Predictors of dependence on opiate medications included substance-related diagnoses, positive toxicology for opiates, and other medical diagnoses. Patients under the care of physicians who have other drug dependence diagnoses and medical complaints appear at risk of developing dependence on prescription opiate medications. Proper evaluation and intervention can limit adverse consequences of prescription opiate medications.
- 1 January 2000
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 18 (1) , 9-16
Effectiveness of coerced addiction treatment (alternative consequences)
- 1 January 2000
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 18 (1) , 9-16
Effectiveness of coerced addiction treatment (alternative consequences)